(Press-News.org) ANN ARBOR, Mich. —A diagnosis of idiopathic pulmonary fibrosis is not much better than a death sentence, given a survival rate averaging 4 to 6 years as the disease robs its victim of the ability to breathe.
But researchers at the University of Michigan have discovered a receptor in the immune system that may serve as a marker for a rapidly progressing form of the disease, which causes the body to produce excess fibrous tissue in the lungs.
More than just signaling which patients have the more aggressive form of IPF – a disease that claims about as many lives each year as breast cancer – the researchers hope that targeting the TLR9 receptor may lead to new treatments that could slow or stop the illness' progression. The findings were published in the Nov. 10 issue of Science Translational Medicine.
"This finding has the potential to allow physicians caring for IPF patients to better determine the natural history of disease in individual patients, which could markedly facilitate decision making for the patient and their doctors," says pulmonologist Fernando J. Martinez, M.D., M.S., a professor of internal medicine at the University of Michigan Medical School and one of the study's two senior authors. "Moreover, it opens the potential for unique therapeutic approaches."
There is no known cause, cure, or FDA-approved treatment for IPF, and it remains virtually unknown to the general public, even though it is several times more common than cystic fibrosis and Lou Gehrig's Disease (or ALS), according to the Coalition for Pulmonary Fibrosis. Moreover, IPF only receives a fraction of the funding of those higher profile conditions.
The U-M led research, which drew on expertise from the Departments of Pathology, Internal Medicine and Radiology, found that TLR9, which stands for Toll-like receptor number 9, causes an increase in the growth of fibrotic tissue in the lungs when it recognizes a particular type of DNA frequently found in bacteria and viruses. Higher amounts of TLR9 were found in patients with rapidly progressing IPF than those with slowly progressing IPF.
The researchers also peered into the workings of IPF by transplanting the disease from humans into mice. Those experiments showed a greater fibrotic response to the TLR9-activating DNA using lung cells from patients with rapidly progressing IPF than with cells from people with slowly progressing IPF.
For more than two decades, the National Institutes of Health has funded the U-M group's investigation into the biological basis of IPF as well as novel ways to diagnose and treat patients who suffer from the devastating disorder. U-M's scientists and doctors study human cells to better understand how they are involved in the progressive scarring of the lungs. In addition, clinical testing is used to help better predict the stage of disease and the rate of progression in advising patients for therapy.
"The approach taken by our group really highlights the advantages of translational research in a complex human disease and shows the bench-to-bedside model is really a two-way street," notes Cory M. Hogaboam, Ph.D., a professor of pathology at U-M and the study's other senior investigator.
INFORMATION:
Additional U-M Authors:
Department of Pathology: Glenda Trujillo, Ph.D. (currently of Stony Brook University Medical Center), Alessia Meneghin, Jeffrey L. Myers, M.D., Sameer R. Oak, Ana Lucia Coelho, Holly Evanoff, Amrita D. Joshi, Matthew A. Schaller, Steve L. Kunkel, Ph.D.
Department of Internal Medicine: Kevin R. Flaherty, M.D., Galen B. Toews, M.D.
Department of Radiology: Ella A. Kazerooni, M.D., Barry H. Gross, M.D.
Other authors:
Lynette M. Sholl, M.D., Brigham and Women's Hospital, Harvard Medical School; Elizabeth Day, Beatrice Waters, Gabor Jarai, John Westwick, all of Novartis Institutes of Biomedical Research, West Sussex, UK.
Funding sources: National Institutes of Health grants and Novartis Institute of Biomedical Research.
Disclosure: Dr. Martinez serves as a paid consultant to Novartis. Dr. Hogaboam conducts UM research supported by Novartis but he has no outside interests in the company.
Citation: Science Translational Medicine, Vol. 2 Issue 57, Nov. 10, 2010.
Resources:
Treatment of IPF at U-M, tinyurl.com/um-ipf
NIH information on IPF, tinyurl.com/what-is-ipf
Coalition for Pulmonary Fibrosis, www.coalitionforpf.org
END
COLUMBIA, Mo. – In modern culture, it is not considered socially acceptable for married people to have extramarital sexual partners. However, in some Amazonian cultures, extramarital sexual affairs were common, and people believed that when a woman became pregnant, each of her sexual partners would be considered part-biological father. Now, a new University of Missouri study published in the journal Proceedings of the National Academy of Sciences has found that up to 70 percent of Amazonian cultures may have believed in the principle of multiple paternity.
"In these cultures, ...
COLUMBUS, Ohio – The genes we possess not only determine the color of our eyes and hair and how our bodies grow, they might also influence the changes that occur in tumors when we develop cancer.
A study by researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that our normal genetic background – the genetic variations that we inherit – contributes to the kinds of DNA changes that occur in tumor cells as cancer develops.
The researchers compared multiple ...
A novel project set in a rural community near Rochester, N.Y., to screen elderly people for unmet needs showed that, indeed, there is a great opportunity to match older adults with professional assistance. This new model of care for rural-dwelling adults is described this month in the Journal of the American Geriatrics Society.
The University of Rochester Medical Center, Livingston County Department of Health and Office for the Aging, and the Genesee Valley Health Partnership collaborated to create this program, called Livingston Help for Seniors.
In one instance, ...
Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births.
Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers — or their babies.
She makes her report in the article, "Antepartum Bed Rest for Pregnancy Complications: Efficacy and Safety for Preventing Preterm Birth," in the special women's health issue ...
CINCINNATI—It's no surprise that being a physician is a very stressful job and carries a lot of responsibility with it.
But two new studies from researchers at the University of Cincinnati (UC) indicate that the stressors arising from work in the clinic, where physicians are seeing patients one-on-one, can effectively be measured with hopes of improving patient care and physician job satisfaction.
Ronnie Horner, PhD, and C. Jeff Jacobson, PhD, both researchers in the department of public health sciences, say their studies, published in online editions of the journal ...
An estimated 26 million people, 13% of the United States population, are living with Chronic Kidney Disease (CKD), and this number continues to grow. If current trends continue, there will not be enough doctors to serve this expanding patient population.
To help address this crisis, the American Society of Nephrology (ASN) is convening a Summit on the Nephrology Workforce during its upcoming ASN Renal Week 2010 in Denver, Colorado, on November 17. Participants will discuss this crisis, its implications, and strategies to increase the number of kidney disease doctors in ...
The Halpin Foundation and the American Society of Nephrology (ASN) proudly highlight the research advances in membranous nephropathy made possible by The Halpin Foundation-ASN Research Grant, created to help young faculty develop independent research careers. This award provides recipients transition funding toward successful application for an NIH RO1 grant.
Elena Torban, PhD (McGill University Faculty of Medicine), the 2008 recipient of The Halpin Foundation-ASN Research Grant, recently explained, "The generous financial two-year support provided by The Halpin Foundation ...
COLUMBIA, Mo. ¬— Underage and heavy drinking on college campuses continue to be issues for college administrators. While some campuses, such as the University of Missouri, have made strides in efforts to reduce heavy drinking on campus, administrators are continually trying to educate students about the risks of excessive drinking. Now, two MU psychologists have found that students who viewed images of beer cans packaged and displayed in university colors believed that drinking beer was less dangerous than those students who saw images of regular beer cans.
"In this research, ...
A team of international researchers led by physicists in the University of Minnesota's College of Science and Engineering have made a significant breakthrough in an effort to understand the phenomenon of high-temperature superconductivity in complex copper-oxides—one of the most studied scientific topics in history.
The University of Minnesota researchers and their international colleagues from Germany, France and China report the discovery of a novel type of magnetic wave involving oxygen atoms. The new findings could have implications for improving superconducting ...
WHAT:
Newly published research by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, sheds light on a poorly understood, acute illness called Immune Reconstitution Inflammatory Syndrome (IRIS) that develops in some HIV-infected individuals soon after they begin antiretroviral therapy.
IRIS affects certain HIV-infected individuals whose immune systems are heavily damaged by the virus and who have a treated or undiagnosed AIDS-associated infection. When these individuals start antiretroviral therapy and ...
